|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Renal cell cancer
Datamonitor, March 2011, Pages: 31
This report provides an estimate and a ten-year forecast of incidence cases of renal cell cancer in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK). Renal cell cancer incident cases are segmented by age and stage at diagnosis.
Features and benefits
- Gain insight into market potential, including a robust 10year epidemiology forecast of renal cell cancer incident cases
- Understand the key epidemiologic risk factors associated with renal cell cancer
Highlights
- In the seven major healthcare markets, in 2010, the incidence of renal cell cancer in men was highest in US (17.9 per 100,000 men), Italy (11.46 per 100,000 men) and Germany (11.36 per 100,000 men) while incidence is substantially lower in women. Generally, renal cell cancer incidence rates are 60% higher in men than in women.
- Between 2010 and 2019, total renal cell incident cases are forecasted to increase by 26% to 128,400 cases
Your key questions answered
- What are the most robust sources for renal cell cancer incidence data?
- How will the patient popilation change over the next decade in the US, Japan and the five major EU markets (France, Germany, Italy, Spain and the UK)?
- How do changes in the population structure and the risk factors affect the trend in incident renal cell cancer cases?
|
|
|
|
